Filing Details
- Accession Number:
- 0001209191-15-023727
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-06 18:34:17
- Reporting Period:
- 2015-03-06
- Filing Date:
- 2015-03-06
- Accepted Time:
- 2015-03-06 18:34:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1509190 | Aratana Therapeutics Inc. | PETX | Pharmaceutical Preparations (2834) | 383826477 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1336284 | Linda Rhodes | C/O Aratana Therapeutics, Inc. 1901 Olathe Boulevard Kansas City KS 66103 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-03-06 | 20,000 | $20.00 | 421,005 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2014.